Publicacións en colaboración con investigadores/as de Hospital Universitario de Valme (14)

2022

  1. Patient Experience Evaluation of the CMO-Based Pharmaceutical Care Model vs Usual Care in People Living with HIV

    Journal of Multidisciplinary Healthcare, Vol. 15, pp. 2991-3003

2021

  1. Association of ABO and Rh blood groups with obstetric outcomes in SARS-CoV-2 infected pregnancies: A prospective study with a multivariate analysis

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 264, pp. 41-48

  2. Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women

    Viruses, Vol. 13, Núm. 1

  3. The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis

    BMC Pregnancy and Childbirth, Vol. 21, Núm. 1

2020

  1. First national survey of the diagnosis of Helicobacter pylori infection in Clinical Microbiology Laboratories in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 410-416

2019

  1. Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386

2018

  1. Spanish Society of Hospital Pharmacy position paper on biosimilar medicines

    Farmacia Hospitalaria, Vol. 42, Núm. 4, pp. 180-183

2017

  1. Development of a risk stratification model for pharmaceutical care in HIV patients

    Farmacia Hospitalaria, Vol. 41, Núm. 3, pp. 346-356

  2. MIC of amoxicillin/clavulanate according to CLSI and EUCAST: Discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 5, pp. 1478-1487

2016

  1. Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: The Bacteraemia-MIC project

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 2, pp. 521-530

2015

  1. Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

    Rheumatology (United Kingdom), Vol. 54, Núm. 7, pp. 1200-1209

2010

  1. Consensus document on the use of biosimilar granulocyte-colony stimulating factor for the correction of neutropenia associated in cancer patients

    Farmacia Hospitalaria, Vol. 34, Núm. SUPPL. 1, pp. 45-50

  2. Metagenomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization

    Journal of Microbiological Methods, Vol. 82, Núm. 1, pp. 98-101

2003

  1. Evolución de la resistencia antibiótica de Pseudomonas aeruginosa, Escherichia coli y Bacteroides fragilis (1997-2001)

    Revista Espanola de Quimioterapia, Vol. 16, Núm. 4, pp. 421-427